| Day Low 09:38 AM EDT | 51.01 | |
|---|---|---|
| Day High 11:27 AM EDT | 51.57 |
|
| Range | 0.56 | |
| Volume | 2.04 M | |
| 30-Day Avg. Vol. | 2.22 M |
|
| Difference | -8.01% | |
| Market Cap. | 140.15 B | |
| Change | 463.92 M | |
| Shares Out. | 2.27 B | |
| Percent Traded | 0.07% | |
| Revenue | 38.26 B | |
| Earnings | 12 B | |
| EPS (TTM) | 2.82 |
| 52-Wk Low 4/17/08 | 46.19 | |
|---|---|---|
| 52-Wk High 1/10/08 | 59.16 |
|
| Range | 12.98 | |
| Prev. Close 5/15/08 | 51.19 | |
| Today's Open | 51.10 | |
| Change | -0.18% | |
| Dividend (TTM) | 1.47 | |
| Div. Yield (TTM) | 2.89% |
|
| Beta | 0.36 | |
| P/E Ratio (TTM) | 18.28 | |
| P/E Ratio (Fwd.) | — |
Although it's based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on four fronts: pharmaceuticals, vaccines and diagnostics, generics, and consumer health. Its largest division, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.72 12/31/07 | 0.40 12/31/07 |
-0.32
Missed
|
| Last Quarter | 0.89 3/31/08 | 1.02 3/31/08 |
0.13
Beat
|
| Quarterly - 12/31/2007 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 9.93 B | 38.27 B |
| Gross Profit | 6.92 B | 27.82 B |
| Operating Income | 657.00 M | 7.51 B |
| Net Income | 904.00 M | 12.01 B |
